Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
Abstract Background The management of acute agitation manifesting in patients with schizophrenia or bipolar disorder requires swift pharmacological intervention to provide rapid symptomatic relief and prevent escalation to aggression and violence. Antipsychotic medications are widely used in this se...
Main Authors: | L. San, G. Estrada, N. Oudovenko, E. Vieta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12888-017-1291-5 |
Similar Items
-
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
by: Faden J, et al.
Published: (2019-08-01) -
Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01) -
Protocol for the management of psychiatric patients with psychomotor agitation
by: Eduard Vieta, et al.
Published: (2017-09-01) -
Exploring the efficacy and tolerability of two‐injection start regimen of long‐acting aripiprazole: A descriptive case series analysis
by: Ibrahim Sungur, et al.
Published: (2024-12-01) -
Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting
by: Scott L. Zeller, MD, et al.
Published: (2016-03-01)